Quadax PAMA Reporting Alternative
Labs that land on Quadax’s PAMA reporting page are usually looking for one fast answer before anything else: does our own Medicare Clinical Laboratory billing even clear the reporting floor. A free PAMA reporting alternative to Quadax’s page exists for exactly that first question, before any conversation about a paid engagement.
What Quadax’s own PAMA page offers
Quadax markets a “PAMA Reporting For Labs” solution page (Quadax, “PAMA Reporting For Labs,” read 2026-08-26), which points visitors to an on-demand webinar and a blog post rather than to a self-serve tool; the page itself does not publish pricing or a way to check a single lab’s own number without contacting Quadax first. Quadax’s companion blog post walks through the applicable-laboratory definition in detail, correctly stating both tests:
more than 50% of its total Medicare revenues from services paid under the CLFS or the physician fee schedule (PFS)
$12,500 from final Medicare paid claims for services paid under the CLFS during the data collection period
Rather than a calculator, that post offers a “PAMA Applicable Lab Decision Tree,” a static flowchart, and states plainly that “Quadax financial reporting quickly and accurately provides the data needed to walk through this process and determine a lab’s status under PAMA,” positioning Quadax’s own paid service as the way to actually get the numbers a lab needs to walk the flowchart.
Where pamawatch fits instead
pamawatch’s checker answers the first half of that flowchart for free and without a sales conversation: enter a lab’s NPI or name and it reads that lab’s own CY2024 Medicare Clinical Laboratory billing, already pulled from CMS’s public data, against the $12,500 threshold Quadax’s own post cites. No webinar signup, no contact form, no account. That is a narrower job than Quadax’s flowchart walks toward, and it is meant to be: a fast, free read on the one number that is public, before deciding whether the harder, private half of the determination is worth a paid engagement at all.
What pamawatch does not replace
pamawatch does not run a lab’s actual PAMA data reporting, does not compute the majority of Medicare revenues share Quadax’s own decision tree also depends on (that share is not public for any single NPI, so no tool, free or paid, can read it from CMS’s data alone), and does not review a lab’s real billing arrangements the way a revenue-cycle engagement would. A lab that clears the $12,500 floor on pamawatch’s checker and finds its revenue mix genuinely does put it over the majority threshold is exactly the lab a service like Quadax’s is built for next; the checker’s job ends where that harder, entity-specific question begins.
Sources, each read this session
Quadax, “PAMA Reporting For Labs,” read 2026-08-26. Quadax, “Is Your Lab Applicable Under the New PAMA Definition?,” read 2026-08-26. CMS, “CLFS & PAMA Reporting and Resources,” read 2026-08-26. For context on another named vendor in the same category: Lighthouse Lab Services, “Is My Lab Required to Report PAMA Data?,” read 2026-08-26 (this page cites a January 1 to June 30, 2019 data collection period rather than a current one; whether that reflects a since-updated page was not confirmed, since a cached view was read during this research pass on 2026-08-26).
Published by Neige AI, Inc. See the method and sources.
This page is independent research, not legal or financial advice. It quotes 42 CFR part 414, 45 CFR 102.3 and Public Law 119-75 with pinpoint citations. Verify anything load-bearing against the primary text itself before acting on it.
See where your lab’s own billing sits before the next reporting cycle
One NPI or lab name, about a minute, no account required.
Check my lab now